Clinical application of the OneDose Patient Dosimetry System for total body irradiation.
The OneDose Patient Dosimetry System (Sicel Technologies) is a new dosimeter based on metal oxide semiconductor field-effect transistor technology and designed for the in vivo measurement of patient dose during radiotherapy. In vivo dosimetry for total body irradiation (TBI) is challenging due to the extended treatment distance, low dose rates and beam spoilers. Phantom results confirm the suitability of the dosimeter for TBI in terms of inherent build-up, post-irradiation fading, accuracy, reproducibility, linearity and temperature dependence. Directional dependence is significant and should be taken into account. The OneDose dosimeters were also trialed in vivo for two TBI patients and the dose measured compared to conventional dosimeter measurements using an ionization chamber and thermoluminescent dosimeters (TLD), with agreement to within 2.2% and 3.9%, respectively. Phantom and patient results confirm that the OneDose patient dosimetry system is a practical and convenient alternative to TLDs for TBI in vivo dosimetry. For increased confidence in results with this dosimeter, we recommend that two dosimeters be used for each site of interest.
Best
S
S
Department of Radiation Oncology, Royal Prince Alfred Hospital, Camperdown, Australia. stephanie.best@email.cs.nsw.gov.au
Ralston
A
A
Suchowerska
N
N
D006801:Humans; D019047:Phantoms, Imaging; D011879:Radiotherapy Dosage; D012666:Semiconductors; D013819:Thermoluminescent Dosimetry; D014916:Whole-Body Irradiation / Q000295:instrumentation*